Search Results for: Therapeutic respiration apparatus
composition each mr (modified release) tablet contains: gliclazide ............................................................................................. mg inactive ingredients: methocel k lv, methocel e lv, colloidal silicon dioxide , microcrystalline cellulose ph , magnesium stearate. therapeutic
lassitude, sleep disorders, agitation, aggression, poor concentration, reduced awareness and slowed reactions, depression, confusion, visual and speech disorders, aphasia, tremor, paresis, sensory disorders, dizziness, feeling of powerlessness, loss of self-control, delirium, convulsions, shallow respiration...
https://kora.egypt.com/PRDSDetails.aspx?id=304